← 返回

病例报告:TIL(肿瘤浸润淋巴细胞)浸润低的预后良好的三阴性乳腺癌:一例反向极性高细胞癌及文献综述

英文原题:Case report: Triple-negative breast cancer with low tumour-infiltrating lymphocytes infiltration and good prognosis: a case of Tall Cell Carcinoma with Reversed Polarity and review of the literature.

查看英文原题

Case report: Triple-negative breast cancer with low tumour-infiltrating lymphocytes infiltration and good prognosis: a case of Tall Cell Carcinoma with Reversed Polarity and review of the literature.

PubMed 2024/11/18(内容时间) Front Oncol Q2 · IF 3.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

TCCRP 是一种罕见的 TNBC,生物学行为惰性,预后良好。我们在此例病理组织中发现 TILs 浸润较低,这可能是 TCCRP 的一个特征,且此例肿瘤间质中存在癌相关成纤维细胞(CAF),可能在一定程度上抑制了抗肿瘤免疫,TCCRP 肿瘤微环境(TME)的免疫特征有待进一步研究。

研究思路结论见上方概要

三阴性乳腺癌(TNBC)由于高转移复发率和缺乏公认的治疗靶点,是临床管理的巨大挑战,而TNBC中TIL(肿瘤浸润淋巴细胞)(TILs)浸润的发现为免疫治疗提供了机会,研究表明TILs浸润水平与TNBC生存呈正相关。我们发现了一例罕见的TILs浸润低但预后良好的TNBC病例,命名为反向极性高细胞癌(TCCRP),并从TILs浸润的角度对其进行研究,以完善TCCRP的临床资料。病例介绍:一名54岁女性,左乳肿块,乳腺超声显示BI-RADS IVb,穿刺诊断为浸润性导管癌,术后病理显示乳头状结构,立方及高柱状排列的细胞,细胞核远离基底部,间质纤维增生,诊断为TCCRP。免疫组化显示肿瘤为三阴性乳腺癌(ER、PR和HER-2阴性),Ki-67增殖指数低。TILs < 10%,伴有少量CD4+和CD8+T淋巴细胞浸润,SMA和FAP阳性表达,IDH2、PIK3CA基因突变。患者接受术后化疗,随访11个月,无复发和转移。

展开英文摘要原文

Triple-negative breast cancer (TNBC) is a great challenge for clinical management due to the high rate of metastatic recurrence and lack of recognised therapeutic targets, while tumour-infiltrating lymphocytes (TILs) infiltration in TNBC has been discovery provides an opportunity for immunotherapy, and studies have suggested that the level of TILs infiltration is positively correlated with TNBC survival. We found a rare case of TNBC with low TILs infiltration but good prognosis, named Tall Cell Carcinoma with Reversed Polarity (TCCRP), and we investigated it from the perspective of TILs infiltration in order to improve the clinical data of TCCRP. CASE PRESENTATION: a 54-year-old woman with a left breast mass, breast ultrasound showed BI-RADS IVb, puncture diagnosis of invasive ductal carcinoma, postoperative pathology showed papillary structure, cubic and high columnar arrangement of cells, nuclei far away from the base, interstitial fibroplasia, diagnosed as TCCRP. Immunohistochemistry revealed that the tumours were triple-negative breast cancer (negative for ER, PR, and HER-2), with a low Ki-67 proliferation index. TILs were < 10%, with a small infiltration of CD4 + and CD8 + T lymphocytes, positive expression of SMA and FAP, and IDH2, PIK3CA gene mutation. The patient underwent postoperative chemotherapy, 11 months follow-up, no recurrence and metastasis.

TCCRP is a rare TNBC with inert biological behaviours and good prognosis. We found low infiltration of TILs in the pathological tissue of this case, which may be a characteristic of TCCRP, and the presence of Cancer-Associated Fibroblasts (CAF) in the interstitium of the tumour in this case may have suppressed the anti-tumour immunity to some extent, and further studies on the immune characteristics of the tumour microenvironment (TME) in TCCRP are needed.

论文信息

作者
Jiao S、Chen J、Shen J、Peng A、Chen R、Lai B、Luo C、Fan Y
单位
Department of Breast, The Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China.China
文献类型
病例报告
期刊
Frontiers in oncology2024
原文标识
PubMed 39624628 · DOI 10.3389/fonc.2024.1455893